The role of beta-blockers in the treatment of XXXX and @entity712 .

@entity1 @entity632 @entity712 @entity1289 @entity296 @entity6 @entity6555 @entity1405 @entity1406 @entity1000 @entity453 @entity6310 @entity29393 @entity340
As first reported by our group in 1975, severe @entity712 due to @entity1000 could be improved in @entity1 receiving beta-blocker therapy starting at a very low dose and followed by a stepwise increase. Since then, these results have been confirmed by our own group and by others, and similar results were also obtained in @entity1 with other forms of @entity296 , including @entity296 . In 13 separate studies involving a total of 651 @entity1 with @entity1000 , beta-blockade for 2 to 19 months (in addition to conventional treatment of @entity712 , including @entity1289 inhibitor therapy), significantly improved cardiac function. These studies were performed using @entity1406 , @entity29393 , @entity6555 and @entity6310 . Eight studies investigated the effects of long term beta-blocker treatment in @entity1 with @entity712 and @entity296 due to @entity453 , @entity340 , @entity6 and @entity632 therapy. A total of 128 @entity1 were treated with @entity1406 , @entity1405 or @entity29393 for periods of 2 to 12 months. All studies reported a significant improvement in cardiac function. Three studies reported results on survival and the need for cardiac transplantation. The first study published by our group reported improved survival in @entity1 with @entity1000 treated with @entity1406 plus digitalis and diuretics compared with a matched control group.(ABSTRACT TRUNCATED AT 250 WORDS)
